{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:49:31Z","timestamp":1788493771992,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00345-019-02739-1","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T04:59:27Z","timestamp":1554353967000},"page":"2289-2296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up"],"prefix":"10.1007","volume":"37","author":[{"given":"Mudhar N.","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Keeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Cracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Traxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palle J\u00f6rn Sloth","family":"Osther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-363X","authenticated-orcid":false,"given":"Marianne","family":"Brehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"issue":"1","key":"2739_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"2739_CR2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1089\/end.2016.0871","volume":"31","author":"M Metcalfe","year":"2017","unstructured":"Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW et al (2017) Induction and maintenance adjuvant mitomycin C topical therapy for upper tract urothelial carcinoma: tolerability and intermediate term outcomes. J Endourol 31(9):946\u2013953","journal-title":"J Endourol"},{"issue":"2","key":"2739_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.urology.2005.03.011","volume":"66","author":"S Holm\u00e4ng","year":"2005","unstructured":"Holm\u00e4ng S, Johansson SL (2005) Urothelial carcinoma of the upper urinary tract: comparison between the WHO\/ISUP 1998 consensus classification and WHO 1999 classification system. Urology 66(2):274\u2013278","journal-title":"Urology"},{"key":"2739_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.humpath.2017.05.001","volume":"65","author":"H Hayashi","year":"2017","unstructured":"Hayashi H, Mann S, Kao CS, Grignon D, Idrees MT (2017) Variant morphology in upper urinary tract urothelial carcinoma: a 14-year case series of biopsy and resection specimens. Hum Pathol 65:209\u2013216","journal-title":"Hum Pathol"},{"issue":"1","key":"2739_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupr\u00eat","year":"2018","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E, Zigeuner R, Sylvester RJ, Burger M et al (2018) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73(1):111\u2013122","journal-title":"Eur Urol"},{"issue":"11","key":"2739_CR6","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/j.1464-410X.2012.11066.x","volume":"110","author":"M Grasso","year":"2012","unstructured":"Grasso M, Fishman AI, Cohen J, Alexander B (2012) Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int 110(11):1618\u20131626","journal-title":"BJU Int"},{"issue":"5","key":"2739_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","volume":"110","author":"ML Cutress","year":"2012","unstructured":"Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA (2012) Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): Systematic review. BJU Int 110(5):614\u2013628","journal-title":"BJU Int"},{"issue":"6","key":"2739_CR8","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/j.clgc.2016.04.017","volume":"14","author":"MM Elawdy","year":"2016","unstructured":"Elawdy MM, Taha DE, Elbaset MA, Abouelkheir RT, Osman Y (2016) Histopathologic characteristics of upper tract urothelial carcinoma with an emphasis on their effect on cancer survival: a single-institute experience with 305 patients with long-term follow-up. Clin Genitourin Cancer 14(6):e609\u2013e615","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"2739_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.juro.2017.07.088","volume":"199","author":"L Villa","year":"2018","unstructured":"Villa L, Haddad M, Capitanio U, Somani BK, Cloutier J, Doizi S et al (2018) Which patients with upper tract urothelial carcinoma can be safely treated with flexible ureteroscopy with holmium:YAG laser photoablation? Long-term results from a high volume institution. J Urol 199(1):66\u201373","journal-title":"J Urol"},{"issue":"1","key":"2739_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/ckj\/sfx149","volume":"11","author":"A Kramer","year":"2018","unstructured":"Kramer A, Pippias M, Noordzij M, Stel VS, Afentakis N, Amb\u00fchl PM et al (2018) The european renal association\u2014European dialysis and transplant association (ERA-EDTA) registry annual report 2015: a summary. Clin Kidney J 11(1):108\u2013122","journal-title":"Clin Kidney J"},{"issue":"3","key":"2739_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrurol.2015.24","volume":"12","author":"T Seisen","year":"2015","unstructured":"Seisen T, Colin P, Roupr\u00eat M (2015) Risk-adapted strategy for the kidney-sparing management of upper tract tumours. Nat Rev Urol 12(3):155\u2013166","journal-title":"Nat Rev Urol"},{"issue":"2","key":"2739_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/21681805.2017.1295102","volume":"51","author":"C Malm","year":"2017","unstructured":"Malm C, Grahn A, Jaremko G, Tribukait B, Brehmer M (2017) Diagnostic accuracy of upper tract urothelial carcinoma: how samples are collected matters. Scand J Urol 51(2):137\u2013145","journal-title":"Scand J Urol"},{"issue":"1","key":"2739_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0022-5347(01)65273-X","volume":"157","author":"FX Keeley","year":"1997","unstructured":"Keeley FX, Kulp DA, Bibbo M, McCue PA, Bagley DH (1997) Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 157(1):33\u201337","journal-title":"J Urol"},{"issue":"12","key":"2739_CR14","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1089\/end.2013.0220","volume":"27","author":"N Kleinmann","year":"2013","unstructured":"Kleinmann N, Healy KA, Hubosky SG, Margel D, Bibbo M, Bagley DH (2013) Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forceps. J Endourol 27(12):1450\u20131454","journal-title":"J Endourol"},{"issue":"1","key":"2739_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1464-410X.2011.10288.x","volume":"109","author":"RL Favaretto","year":"2012","unstructured":"Favaretto RL, Shariat SF, Savage C, Godoy G, Chade DC, Kaag M et al (2012) Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 109(1):77\u201382","journal-title":"BJU Int"},{"issue":"5","key":"2739_CR16","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.juro.2012.10.057","volume":"189","author":"M Roupr\u00eat","year":"2013","unstructured":"Roupr\u00eat M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR et al (2013) Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol 189(5):1662\u20131669","journal-title":"J Urol"},{"issue":"4","key":"2739_CR17","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","volume":"189","author":"DA Green","year":"2013","unstructured":"Green DA, Rink M, Xylinas E, Matin SF, Stenzl A, Roupret M et al (2013) Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol 189(4):1214\u20131221","journal-title":"J Urol"},{"issue":"4","key":"2739_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1470-2045(09)70041-5","volume":"10","author":"JJ Koornstra","year":"2009","unstructured":"Koornstra JJ, Mourits MJ, Sijmons RH, Leliveld AM, Hollema H, Kleibeuker JH (2009) Management of extracolonic tumours in patients with Lynch syndrome. Lancet Oncol 10(4):400\u2013408","journal-title":"Lancet Oncol"},{"issue":"2","key":"2739_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM200001133420201","volume":"342","author":"R Gryfe","year":"2000","unstructured":"Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB et al (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342(2):69\u201377","journal-title":"N Engl J Med"},{"issue":"6","key":"2739_CR20","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.urology.2005.01.019","volume":"65","author":"M Roupr\u00eat","year":"2005","unstructured":"Roupr\u00eat M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, Cussenot O (2005) Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Urology 65(6):1233\u20131237","journal-title":"Urology"},{"issue":"6","key":"2739_CR21","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.juro.2016.01.006","volume":"195","author":"A Bagrodia","year":"2016","unstructured":"Bagrodia A, Cha EK, Sfakianos JP, Zabor EC, Bochner BH, Al-Ahmadie HA et al (2016) Genomic biomarkers for the prediction of stage and prognosis of upper tract urothelial carcinoma. J Urol 195(6):1684\u20131689","journal-title":"J Urol"},{"key":"2739_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2017.10.003","author":"B Peyronnet","year":"2017","unstructured":"Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam T et al (2017) Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an European Association of Urology guidelines systematic review. Eur Urol Focus. \n                    https:\/\/doi.org\/10.1016\/j.euf.2017.10.003","journal-title":"Eur Urol Focus"},{"issue":"3","key":"2739_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.eururo.2009.06.013","volume":"56","author":"G Simone","year":"2009","unstructured":"Simone G, Papalia R, Guaglianone S, Ferriero M, Leonardo C, Forastiere E, Gallucci M (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56(3):520\u2013526","journal-title":"Eur Urol"},{"issue":"4","key":"2739_CR24","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.urology.2007.01.007","volume":"69","author":"M Roupr\u00eat","year":"2007","unstructured":"Roupr\u00eat M, Hupertan V, Sanderson KM, Harmon JD, Cathelineau X, Barret E et al (2007) Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Urology 69(4):656\u2013661","journal-title":"Urology"},{"issue":"6","key":"2739_CR25","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.urology.2007.01.088","volume":"69","author":"SD Chung","year":"2007","unstructured":"Chung SD, Huang CY, Chueh SC, Pu YS, Lai MK, Yu HJ, Huang KH (2007) Intermediate follow-up of hand-assisted retroperitoneoscopic nephroureterectomy for management of upper urinary tract urothelial carcinoma: comparison with open nephroureterectomy. Urology 69(6):1030\u20131034","journal-title":"Urology"},{"issue":"1","key":"2739_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/end.2008.0267","volume":"23","author":"SD Chung","year":"2009","unstructured":"Chung SD, Chen SC, Wang SM, Chueh SC, Lai MK, Huang CY et al (2009) Long-term outcome of hand-assisted laparoscopic nephroureterectomy for pathologic T3 upper urinary tract urothelial carcinoma. J Endourol 23(1):75\u201380","journal-title":"J Endourol"},{"issue":"9","key":"2739_CR27","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/j.1464-410X.2009.08594.x","volume":"104","author":"F Greco","year":"2009","unstructured":"Greco F, Wagner S, Hoda RM, Hamza A, Fornara P (2009) Laparoscopic vs open radical nephroureterectomy for upper urinary tract urothelial cancer: oncological outcomes and 5-year follow-up. BJU Int 104(9):1274\u20131278","journal-title":"BJU Int"},{"issue":"5","key":"2739_CR28","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.juro.2015.11.036","volume":"195","author":"T Seisen","year":"2016","unstructured":"Seisen T, Nison L, Remzi M, Klatte T, Mathieu R, Lucca I et al (2016) Oncologic outcomes of kidney sparing surgery versus radical nephroureterectomy for the elective treatment of clinically organ confined upper tract urothelial carcinoma of the distal ureter. J Urol 195(5):1354\u20131361","journal-title":"J Urol"},{"issue":"6","key":"2739_CR29","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","volume":"70","author":"T Seisen","year":"2016","unstructured":"Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY, Babjuk M et al (2016) Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol 70(6):1052\u20131068","journal-title":"Eur Urol"},{"issue":"11","key":"2739_CR30","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1111\/j.1464-410X.2012.11169.x","volume":"110","author":"ML Cutress","year":"2012","unstructured":"Cutress ML, Stewart GD, Wells-Cole S, Phipps S, Thomas BG, Tolley DA (2012) Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int 110(11):1608\u20131617","journal-title":"BJU Int"},{"issue":"5","key":"2739_CR31","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0022-5347(01)64793-1","volume":"157","author":"FX Keeley","year":"1997","unstructured":"Keeley FX, Bibbo M, Bagley DH (1997) Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol 157(5):1560\u20131565","journal-title":"J Urol"},{"issue":"2","key":"2739_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ucl.2017.12.009","volume":"45","author":"FG Petros","year":"2018","unstructured":"Petros FG, Li R, Matin SF (2018) Endoscopic approaches to upper tract urothelial carcinoma. Urol Clin N Am 45(2):267\u2013286","journal-title":"Urol Clin N Am"},{"issue":"Suppl 2","key":"2739_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1464-410X.2005.05210.x","volume":"95","author":"GB Johnson","year":"2005","unstructured":"Johnson GB, Fraiman M, Grasso M (2005) Broadening experience with the retrograde endoscopic management of upper urinary tract urothelial malignancies. BJU Int 95(Suppl 2):110\u2013113","journal-title":"BJU Int"},{"issue":"2","key":"2739_CR34","first-page":"113","volume":"2","author":"EI Engelmyer","year":"1996","unstructured":"Engelmyer EI, Belis JA (1996) Long-term ureteroscopic management of low-grade transitional cell carcinoma of the upper urinary tract. Tech Urol 2(2):113\u2013116","journal-title":"Tech Urol"},{"key":"2739_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2490-14-97","volume":"14","author":"A Hoffman","year":"2014","unstructured":"Hoffman A, Yossepowitch O, Erlich Y, Holland R, Lifshitz D (2014) Oncologic results of nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy\u2014a case control study. BMC Urol 14:97","journal-title":"BMC Urol"},{"issue":"2","key":"2739_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.urology.2007.03.065","volume":"70","author":"K Reisiger","year":"2007","unstructured":"Reisiger K, Hruby G, Clayman RV, Landman J (2007) Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome. Urology 70(2):263\u2013266","journal-title":"Urology"},{"issue":"6","key":"2739_CR37","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1089\/end.2008.0187","volume":"22","author":"DJ Painter","year":"2008","unstructured":"Painter DJ, Denton K, Timoney AG, Keeley FX (2008) Ureteroscopic management of upper-tract urothelial cancer: an exciting nephron-sparing option or an unacceptable risk? J Endourol 22(6):1237\u20131239","journal-title":"J Endourol"},{"issue":"6","key":"2739_CR38","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1464-410X.2006.06519.x","volume":"98","author":"RE Zigeuner","year":"2006","unstructured":"Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C (2006) Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 98(6):1181\u20131186","journal-title":"BJU Int"},{"issue":"4","key":"2739_CR39","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"T O'Brien","year":"2011","unstructured":"O'Brien T, Ray E, Singh R, Coker B, Beard R, British Association of Urological Surgeons Section of Oncology (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial). Eur Urol 60(4):703\u2013710","journal-title":"Eur Urol"},{"issue":"2","key":"2739_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bju.14053","volume":"121","author":"RQ Guo","year":"2018","unstructured":"Guo RQ, Hong P, Xiong GY, Zhang L, Fang D, Li XS et al (2018) Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int 121(2):184\u2013193","journal-title":"BJU Int"},{"key":"2739_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.urology.2016.05.039","volume":"94","author":"A Sankin","year":"2016","unstructured":"Sankin A, Tin AL, Mano R, Chevinsky M, Jakubowski C, Sfakianos JP et al (2016) Impact of ureteroscopy before nephroureterectomy for upper tract urothelial carcinoma on oncologic outcomes. Urology 94:148\u2013153","journal-title":"Urology"},{"issue":"3","key":"2739_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/bju.13935","volume":"120","author":"M Marchioni","year":"2017","unstructured":"Marchioni M, Primiceri G, Cindolo L, Hampton LJ, Grob MB, Guruli G et al (2017) Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis. BJU Int 120(3):313\u2013319","journal-title":"BJU Int"},{"issue":"5","key":"2739_CR43","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1089\/end.2010.0396","volume":"25","author":"C Gurbuz","year":"2011","unstructured":"Gurbuz C, Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI et al (2011) The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. J Endourol 25(5):775\u2013779","journal-title":"J Endourol"},{"issue":"4","key":"2739_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11934-017-0675-x","volume":"18","author":"DP Verges","year":"2017","unstructured":"Verges DP, Lallas CD, Hubosky SG, Bagley DH (2017) Endoscopic treatment of upper tract urothelial carcinoma. Curr Urol Rep 18(4):31","journal-title":"Curr Urol Rep"},{"issue":"9","key":"2739_CR45","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00345-015-1753-7","volume":"34","author":"L Villa","year":"2016","unstructured":"Villa L, Cloutier J, Letendre J, Ploumidis A, Salonia A, Cornu JN et al (2016) Early repeated ureteroscopy within 6\u20138 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings. World J Urol 34(9):1201\u20131206","journal-title":"World J Urol"},{"issue":"5","key":"2739_CR46","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","volume":"68","author":"M Roupr\u00eat","year":"2015","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E, Zigeuner R, Sylvester RJ, Burger M et al (2015) European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol 68(5):868\u2013879","journal-title":"Eur Urol"},{"key":"2739_CR47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.urology.2018.05.042","volume":"121","author":"KB Scotland","year":"2018","unstructured":"Scotland KB, Kleinmann N, Cason D, Hubbard L, Tanimoto R, Healy KA et al (2018) Ureteroscopic management of large \u2265 2 cm upper tract urothelial carcinoma: a comprehensive 23-year experience. Urology 121:66\u201373","journal-title":"Urology"},{"issue":"3","key":"2739_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrurol.2016.252","volume":"14","author":"J Baard","year":"2017","unstructured":"Baard J, de Bruin DM, Zondervan PJ, Kamphuis G, de la Rosette J, Laguna MP (2017) Diagnostic dilemmas in patients with upper tract urothelial carcinoma. Nat Rev Urol 14(3):181\u2013191","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2739_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.juro.2010.03.030","volume":"184","author":"JC Brien","year":"2010","unstructured":"Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B et al (2010) Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184(1):69\u201373","journal-title":"J Urol"},{"issue":"5","key":"2739_CR50","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.eururo.2017.04.015","volume":"72","author":"V Soukup","year":"2017","unstructured":"Soukup V, \u010capoun O, Cohen D, Hern\u00e1ndez V, Babjuk M, Burger M et al (2017) Prognostic performance and reproducibility of the 1973 and 2004\/2016 World Health Organization grading classification systems in non-muscle-invasive bladder cancer: a European association of urology non-muscle invasive bladder cancer guidelines panel systematic review. Eur Urol 72(5):801\u2013813","journal-title":"Eur Urol"},{"issue":"1","key":"2739_CR51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.urology.2011.02.038","volume":"78","author":"AK Smith","year":"2011","unstructured":"Smith AK, Stephenson AJ, Lane BR, Larson BT, Thomas AA, Gong MC et al (2011) Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology 78(1):82\u201386","journal-title":"Urology"},{"issue":"3","key":"2739_CR52","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.urology.2011.11.049","volume":"79","author":"JK Wang","year":"2012","unstructured":"Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH (2012) High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology 79(3):615\u2013619","journal-title":"Urology"},{"issue":"4","key":"2739_CR53","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.eururo.2014.04.014","volume":"67","author":"M Gerlinger","year":"2015","unstructured":"Gerlinger M, Catto JW, Orntoft TF, Real FX, Zwarthoff EC, Swanton C (2015) Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications. Eur Urol 67(4):729\u2013737","journal-title":"Eur Urol"},{"issue":"1","key":"2739_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MOU.0000000000000341","volume":"27","author":"SF Kammerer-Jacquet","year":"2017","unstructured":"Kammerer-Jacquet SF, Mathieu R, Peyronnet B, Rioux-Leclercq N, Bensalah K (2017) Genomics in upper tract urothelial carcinoma. Curr Opin Urol 27(1):35\u201340","journal-title":"Curr Opin Urol"},{"issue":"6","key":"2739_CR55","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","volume":"68","author":"JP Sfakianos","year":"2015","unstructured":"Sfakianos JP, Cha EK, Iyer G, Scott SN, Zabor EC, Shah RH et al (2015) Genomic characterization of upper tract urothelial carcinoma. Eur Urol 68(6):970\u2013977","journal-title":"Eur Urol"},{"key":"2739_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2018.01.005","author":"A Bagrodia","year":"2018","unstructured":"Bagrodia A, Audenet F, Pietzak EJ, Kim K, Murray KS, Cha EK et al (2018) Genomic profile of urothelial carcinoma of the upper tract from ureteroscopic biopsy: feasibility and validation using matched radical nephroureterectomy specimens. Eur Urol Focus. \n                    https:\/\/doi.org\/10.1016\/j.euf.2018.01.005","journal-title":"Eur Urol Focus"},{"issue":"3","key":"2739_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00345-014-1311-8","volume":"33","author":"S Hurel","year":"2015","unstructured":"Hurel S, Roupr\u00eat M, Seisen T, Comperat E, Ph\u00e9 V, Droupy S et al (2015) Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy. World J Urol 33(3):335\u2013341","journal-title":"World J Urol"},{"issue":"1","key":"2739_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/0886022X.2015.1103638","volume":"38","author":"KH Lee","year":"2016","unstructured":"Lee KH, Chen YT, Chung HJ, Liu JS, Hsu CC, Tarng DC (2016) Kidney disease progression in patients of upper tract urothelial carcinoma following unilateral radical nephroureterectomy. Ren Fail 38(1):77\u201383","journal-title":"Ren Fail"},{"issue":"6","key":"2739_CR59","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","volume":"67","author":"T Seisen","year":"2015","unstructured":"Seisen T, Granger B, Colin P, L\u00e9on P, Utard G, Renard-Penna R et al (2015) A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol 67(6):1122\u20131133","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02739-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-02739-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02739-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T12:13:53Z","timestamp":1585916033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-02739-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2739"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-02739-1","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"30 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mudhar Hasan: no conflict of interest. Morgan Roupr\u00eat: advisory board for Ipsen, Roche, Astra Zeneca, Janssen, GSK, and Arquer. Francis X Keeley: no conflict of interest. Olivier Traxer: consultant for Coloplast, Boston Scientific, Olympus, Rocamed, EMS, and IPG Medical. Michael Straub: consultant for Richard Wolf Endoscopes, Coloplast-Porg\u00e8s, and Ambu. Palle J\u00f6rn Sloth Osther: no conflict of interest. Cecilia Cracco: tutor for courses for Boston Scientific. Robert Jones: consultant and speaker for Roche, Bristol Myers Squibb, and MSD. Marianne Brehmer: no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a review article involving no studies on human participants and\/or animals. Informed consent is not relevant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}